Artelo Biosciences (NASDAQ:ARTL) just reported results for the second quarter of 2024.
- Artelo Biosciences reported earnings per share of -75 cents. This was above the analyst estimate for EPS of -85 cents.
- The company did not report any revenue for the quarter.